Advanced Cell Agrees To Pay $4M Over Alleged Stock Scheme

Law360, Miami (January 2, 2014, 5:24 PM EST) -- Advanced Cell Technology Inc. on Monday agreed to pay $4.1 million to resolve allegations by the U.S. Securities and Exchange Commission that the biotechnology firm issued unregistered penny stocks through sham legal settlements in a long-running scheme.

Advanced Cell Technology, which did not admit or deny the allegations, will disgorge $3.5 million in profits allegedly gained in the scheme plus prejudgment interest of $586,619, according to a final judgment issued in the Middle District of Florida by U.S. District Judge Mary S. Scriven.

The SEC did...
To view the full article, register now.




Case Information

Case Title

Securities and Exchange Commission v. Lefkowitz et al

Case Number



Florida Middle

Nature of Suit



Mary S. Scriven

Date Filed

May 30, 2012

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.